Searched for
WEGOVY VS MOUNJARO
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- Weight-loss drug boom: Will cheaper Ozempic generics shake up India’s fitness and nutrition industry?The rise of GLP-1 weight-loss drugs such as Ozempic is posing a challenge to the fitness industry, with cheaper generic versions expected t...
- Patent expiry looms: Eli Lilly and Novo Nordisk strategise to defend their top obesity drugs in IndiaAt a recent industry summit, executives from Eli Lilly and Novo Nordisk unveiled their game plan for tackling weight-loss medications in In...
- Dr Reddy’s gets nod to make generic semaglutide for weight lossDr Reddy's Laboratories is set to launch generic semaglutide, a popular weight loss drug. An expert committee has approved their proposal. ...
- After Mounjaro Jab, Eli Lilly plans weight loss pill launch in IndiaEli Lilly plans to launch an oral weight loss drug, orforglipron, after Mounjaro's India success. Regulatory submissions are expected soon,...
- Obesity lab: India becomes ground zero for weight-loss drug raceIndia is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expi...
- Novo Nordisk’s Wegovy enters India: Can this weight loss jab beat Mounjaro? Price, who can use it & how it worksNovo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy conta...
- Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other detailsNovo Nordisk has introduced its weight-loss drug, Wegovy, in India. This launch follows Eli Lilly's entry into the market. The company aims...
- ₹14,000 per month weight-loss shot is here to cash in on India’s obesity crisisEli Lilly Weight Loss Drug: India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to ...
- Are you really obese? Experts challenge BMI as only measure of obesity, propose new guidelines for better healthA new report from global experts calls for redefining obesity beyond the traditional body mass index (BMI) measurement. The experts propose...
Load More
